Dickinsons Original Witch Hazel Exfoliating Bubble Toner

Description

Dickinson's Original Witch Hazel is an alcohol- and fragrance-free formulation designed for acne treatment. It contains 0.5% salicylic acid, 2% glycolic acid, and polyhydroxy acids (PHA), which work synergistically to address acne concerns. The product is powered by 100% natural distilled witch hazel, known for its soothing properties. The dosage form is a liquid, presented in a 5 fluid ounce (147 mL) container.

Uses and Indications

This drug is indicated for the treatment of acne. It assists in keeping the skin clear of new acne blemishes and helps prevent the development of new acne pimples.

Dosage and Administration

Healthcare professionals are advised to ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended dosage involves dispensing one pump of the product onto the fingertips. A thin layer should be applied to the entire affected area one to three times daily, depending on the severity of the condition.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to once a day or every other day to mitigate these side effects.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance should be sought or the Poison Control Center contacted.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. In cases where irritation occurs, it is recommended to limit the use to one topical acne medication at a time to mitigate adverse effects.

This product contains an alpha hydroxy acid (AHA), which may heighten the skin's sensitivity to sunlight, thereby increasing the risk of sunburn. Patients should be counseled to apply a broad-spectrum sunscreen, wear protective clothing, and limit sun exposure during the use of this product and for at least one week following discontinuation.

It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients using this product may experience skin irritation and dryness, particularly if they concurrently use another topical acne medication. It is advised that only one topical acne medication be used at a time to minimize the risk of irritation.

The formulation contains an alpha hydroxy acid (AHA), which may heighten the skin's sensitivity to sunlight, increasing the likelihood of sunburn. Patients are encouraged to use sunscreen, wear protective clothing, and limit sun exposure while using this product and for at least one week following its use.

In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately. This product is intended for external use only.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Dickinsons Original Witch Hazel Exfoliating Bubble Toner (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of Dickinson's Original Witch Hazel Exfoliating Bubble Toner in geriatric patients. The drug insert does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when recommending this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of the patient's response to treatment.

Pregnancy

There is no information available regarding the use of Dickinson's Original Witch Hazel Exfoliating Bubble Toner during pregnancy. As such, the safety of this product in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when advising women of childbearing potential regarding the use of this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact the Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact the Poison Control Center immediately.

Additionally, it is important to inform patients that the use of this medication may lead to skin irritation and dryness, particularly if they are using another topical acne medication concurrently. Patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation. If they experience any signs of irritation, they should discontinue use and consult their healthcare provider for further guidance.

Storage and Handling

The product is supplied in a container that must be stored at room temperature. It is essential to protect the container from light exposure to maintain product integrity. The container should be kept tightly closed when not in use to prevent contamination. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Dickinsons Original Witch Hazel Exfoliating Bubble Toner, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)